Circle (CRCL) stock slips into year-end close as Fed minutes keep rate bets in focus

Circle (CRCL) stock slips into year-end close as Fed minutes keep rate bets in focus

NEW YORK, December 30, 2025, 20:36 ET — Market closed

  • Circle shares closed at $79.89, down about 0.7%, after swinging between $79.68 and $82.88. Finviz
  • Investors are weighing the Fed’s rate outlook against stablecoin growth, a key driver of Circle’s reserve income. Reuters
  • Bitcoin rose about 0.7% on the day, keeping crypto-linked stocks in focus into the final U.S. session of 2025. Reuters

Circle Internet Group shares ended lower on Tuesday, closing at $79.89 as U.S. stocks eased in holiday-thin trading. The USDC stablecoin issuer traded between $79.68 and $82.88. Reuters

The stock’s sensitivity to interest rates is front and center heading into year-end. Circle’s core earnings power is tied to yield on cash and short-dated government assets backing USDC, a type of cryptocurrency designed to hold a steady $1 value. Circle

That makes the Federal Reserve’s policy path a near-term driver as investors debate how quickly borrowing costs may fall in 2026. Minutes from the Fed’s latest meeting underscored divisions on the outlook, Reuters reported. Reuters

U.S. stocks slipped modestly on Tuesday, while bitcoin rose 0.74% to $87,888.55, Reuters data showed. Risk appetite in crypto and the direction of yields often feed into trading in companies tied to digital-asset activity. Reuters

Other crypto-linked names were mixed late Tuesday. Coinbase fell about 0.9%, while Strategy was little changed.

Circle’s own daily metrics remain a key watch for investors trying to handicap revenue momentum. The company’s website showed USDC in circulation at $75.9 billion as of Dec. 29. Circle

Circle says USDC reserves are held in highly liquid assets, with the majority of the reserve in the Circle Reserve Fund (USDXX), an SEC-registered 2a-7 government money market fund managed by BlackRock. Those portfolios typically hold cash, short-dated U.S. Treasuries and overnight Treasury repurchase agreements. Circle

For traders, the setup is straightforward: softer yields can squeeze the interest income Circle earns on reserves, while growth in USDC supply can expand the base those yields apply to. The Fed minutes kept both sides of that equation in play late Tuesday. Reuters

Before Wednesday’s final U.S. trading session of 2025, investors will watch Treasury yields and crypto prices for cues on positioning into the New Year holiday. Reuters described Tuesday’s session as light-volume and pre-holiday. Reuters

“Solid corporate profits can make up for a lot of sins,” Ryan Detrick, chief market strategist at Carson Group, told Reuters in a broader year-end markets recap. For Circle, investors are looking for evidence that USDC growth and take-up beyond crypto trading can keep earnings resilient as the rate cycle turns. Reuters

Technically, $80 is the near-term line traders are watching after Tuesday’s dip, with the day’s low around $79.68 and resistance near $83, close to Tuesday’s intraday high.

The next major company-specific catalyst is Circle’s next quarterly update. The latest earnings call posted on Circle’s investor relations site was for Nov. 12. Circle Investor Relations

With U.S. markets shut on New Year’s Day and crypto trading around the clock, any sharp moves in bitcoin, stablecoin flows, or rate expectations are likely to show up first in extended-hours pricing — and then in Circle’s next regular-session open. Reuters

Stock Market Today

  • Tempus AI Hits $1.1B Contracts and Positive EBITDA in 2025; Industry Peers Expand
    January 21, 2026, 9:47 AM EST. Tempus AI, Inc. (TEM) surpassed $1.1 billion in Total Contract Value by end-2025, partnering with over 70 pharma giants like AstraZeneca and Pfizer. It posted its first positive adjusted EBITDA of $1.5 million in Q3 2025, signaling financial progress. The company's AI platform underpins nearly 1,500 research projects, facilitating drug discovery with its multimodal datasets and diagnostic assays. Meanwhile, peer Hims & Hers (HIMS) doubled revenues with international expansions in Canada and Europe, acquiring platforms such as Livewell and ZAVA. Omnicell (OMCL) advanced healthcare automation with the Titan XT automated dispensing system and launched an innovation lab in Austin to optimize medication management. These developments highlight growing momentum and innovation across digital health and biopharma services in 2025.
Coca-Cola stock today slips on thin year-end trade — here’s what investors watch next
Previous Story

Coca-Cola stock today slips on thin year-end trade — here’s what investors watch next

MercadoLibre stock closes higher as year-end trading thins; Fed minutes keep rates in focus
Next Story

MercadoLibre stock closes higher as year-end trading thins; Fed minutes keep rates in focus

Go toTop